Brief: Australian Govt Takeovers Panel Says It Declines To Conduct Proceedings On Healius
April 17 (Reuters) -
Australian Government Takeovers Panel:
* DECLINED TO CONDUCT PROCEEDINGS
* HAD CONCERNS IN RELATION TO DISCLOSURE IN RBS REGARDING
IMPACT
OF ACL ACQUIRING LESS THAN 90% OF HEALIUS SHARES
* PANEL CONCLUDED THERE WAS NO REASONABLE PROSPECT THAT IT
WOULD
MAKE A DECLARATION OF UNACCEPTABLE CIRCUMSTANCES
* PANEL WAS SATISFIED ITS CONCERNS WERE SUFFICIENTLY
ADDRESSED IN
RBS (AS AMENDED)
Source text for Eikon: ID:nASX2D0PmT
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million